Biocon tanks 10% on lower-than-expected December quarter results

Due to professional differences with the chairperson on strategic priorities and the vision for the company, Dr Christiane Hamacher has stepped down as the MD of Biocon Biologics

Premium

The company's Ebitda declined 10.1 per cent YoY to Rs 400 crore in Q3FY21

Mumbai

3 min read Last Updated : Jan 22 2021 | 10:26 AM IST

Shares of Biocon plunged 10 per cent to Rs 400 on the BSE in the morning deals on Friday after the company posted below par December quarter (Q3FY21) results, with

Topics : Buzzing stocks Biocon Q3 results biocon stock

First Published: Jan 22 2021 | 10:09 AM IST

Explore News

Stock Market Updates Stocks to Watch Today OPPO Find N3 Flip Latest News Live Asian Games LIVE updates AAP Releases 2nd List of Candidates India GDP Growth Asian Games 2023 October 03 Schedule Asian Games Medal Tally Gold-Silver Price

Companies News

RSOLEC to invest $300 million into solar manufacturing venture in India JSW Infrastructure has huge potential to grow its business: Sajjan Jindal

Sports News

Cricket World Cup 2023: New Zealand full schedule, squad, timing, streaming ICC World Cup 2023: List of commentators announced-Shastri, Ponting & more

India News

Earthquake tremors felt in Delhi-NCR; 6.2 magnitude recorded in Nepal IRCTC launches 4 days/3 nights Chennai-Shirdi package for devotees

Economy News

World Bank maintains India GDP growth at 6.3 % for FY24, cites investments Manufacturing PMI at five-month low in Sept but remains strong: Survey

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Continue

Biocon tanks 10% on lower-than-expected December quarter results

Due to professional differences with the chairperson on strategic priorities and the vision for the company, Dr Christiane Hamacher has stepped down as the MD of Biocon Biologics

Also Read

Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

Biocon gains 2% after arm gets Rs 555 crore capital injection from ADQ

Biocon dips 11% in three days on disappointing September quarter results

Biocon: Street to keep an eye on CY21 launches, market share gains

Biocon-Mylan launch insulin Glargine at lowest price in US market

JK Tyre zooms 51% in 4 days, hits fresh 52-week high on robust Q3 results

Stocks to watch: RIL, YES Bank, Vedanta, HDFC Bank, SBI Card, Biocon

Market Ahead, January 22: All you need to know before the opening bell

Market Ahead, January 22: All you need to know before the opening bell

MARKETS: Sensex, Nifty decline, broader indices outperform; Biocon dips 10%

Explore News